Quasar Medical is sharpening its global edge with the acquisition of Nordson MEDICAL’s design and development sites in Galway and Tecate. This move signals a major shift in the contract manufacturing landscape—one that strengthens Quasar’s capabilities in catheter systems, balloon tech, and scalable production across three continents.

By folding in FDA-registered and ISO-certified operations, along with 50+ new product development engineers and 800,000 square feet of manufacturing space, Quasar now offers OEMs a seamless, end-to-end solution—from concept to full-scale assembly—closer to key markets in the US and EU.

For providers and device innovators under pressure to cut time-to-market without sacrificing quality, Quasar’s expanded footprint offers more than speed. It brings flexibility, cost-efficiency, and regional manufacturing intelligence—all under a single CDMO partner with global reach.

Read the full article to explore what this means for your next-generation device pipeline.